Capital Performance Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-163
Closed -$148 1516
2024
Q3
$148 Buy
+163
New +$148 ﹤0.01% 2623